Raymond J Harbert insider trades: Enzo Biochem (ENZ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Raymond reports to the SEC
and 53 more companies
Open-market buys and sales
532 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | ENZ | ↓ Sell | 344,768 | $4.69 | $1.6M | Indirect | Mar 17, 2021 (1d) |
| Mar 15, 2021 | ENZ | ↓ Sell | 100,000 | $4.75 | $475K | Indirect | Mar 17, 2021 (2d) |
| Nov 7, 2019 | QUMU | ↑ Buy | 100,000 | $2.50 | $250K | Direct | Nov 12, 2019 (5d) |
| Aug 20, 2019 | ENZ | ↑ Buy | 9,700 | $3.11 | $30K | Indirect | Aug 20, 2019 (0d) |
| Aug 16, 2019 | ENZ | ↑ Buy | 22,800 | $3.06 | $70K | Indirect | Aug 20, 2019 (4d) |
| Jul 23, 2019 | ENZ | ↑ Buy | 409,200 | $3.65 | $1.5M | Indirect | Jul 24, 2019 (1d) |
| Jul 22, 2019 | ENZ | ↑ Buy | 9,644 | $3.64 | $35K | Indirect | Jul 24, 2019 (2d) |
| May 30, 2019 | ENZ | ↑ Buy | 52,118 | $3.07 | $160K | Indirect | May 30, 2019 (0d) |
| May 28, 2019 | ENZ | ↑ Buy | 50,000 | $3.10 | $155K | Indirect | May 30, 2019 (2d) |
| May 20, 2019 | ENZ | ↑ Buy | 14,132 | $3.61 | $51K | Indirect | May 22, 2019 (2d) |
| Nov 9, 2018 | QUMU | ↑ Buy | 47,193 | $2.52 | $119K | Direct | Nov 13, 2018 (4d) |
| May 21, 2018 | QUMU | ↑ Buy | 20,000 | $2.39 | $48K | Direct | May 23, 2018 (2d) |
| Nov 13, 2017 | QUMU | ↑ Buy | 103,450 | $2.46 | $255K | Direct | Nov 13, 2017 (0d) |
| Nov 3, 2017 | QUMU | ↑ Buy | 156,709 | $2.44 | $382K | Direct | Nov 3, 2017 (0d) |
| Feb 24, 2009 | SRLS | ↓ Sell | 3,572,569 | $0.27 | $966K | Direct | Feb 25, 2009 (1d) |
| Feb 20, 2009 | SRLS | ↓ Sell | 24,600 | $0.46 | $11K | Direct | Feb 23, 2009 (3d) |
| Feb 18, 2009 | CPN | ↑ Buy | 150,000 | $6.37 | $956K | Direct | Feb 20, 2009 (2d) |
| Feb 18, 2009 | SRLS | ↓ Sell | 29,100 | $0.68 | $20K | Direct | Feb 19, 2009 (1d) |
| Feb 10, 2009 | SRLS | ↓ Sell | 10,500 | $0.95 | $10K | Direct | Feb 12, 2009 (2d) |
| Feb 5, 2009 | SRLS | ↓ Sell | 35,801 | $1.09 | $39K | Direct | Feb 9, 2009 (4d) |
| Feb 4, 2009 | SRLS | ↓ Sell | 60,800 | $0.99 | $60K | Direct | Feb 5, 2009 (1d) |
| Feb 3, 2009 | CLF | ↓ Sell | 1,294,100 | $22.61 | $29.3M | Direct | Feb 4, 2009 (1d) |
| Jan 30, 2009 | SRLS | ↓ Sell | 81,000 | $1.01 | $82K | Direct | Feb 3, 2009 (4d) |
| Jan 30, 2009 | CPN | ↑ Buy | 1,250,594 | $7.29 | $9.1M | Direct | Feb 2, 2009 (3d) |
| Jan 28, 2009 | SRLS | ↓ Sell | 23,000 | $1.07 | $25K | Direct | Jan 30, 2009 (2d) |
| Jan 26, 2009 | SRLS | ↓ Sell | 112,000 | $1.11 | $124K | Direct | Jan 27, 2009 (1d) |
| Jan 22, 2009 | NAV | ↓ Sell | 934,308 | $28.11 | $26.3M | Direct | Jan 22, 2009 (0d) |
| Jan 22, 2009 | SRLS | ↓ Sell | 305,302 | $1.12 | $341K | Direct | Jan 22, 2009 (0d) |
| Jan 16, 2009 | NAV | ↓ Sell | 1,747,400 | $27.28 | $47.7M | Direct | Jan 20, 2009 (4d) |
| Jan 16, 2009 | SRLS | ↓ Sell | 66,700 | $1.35 | $90K | Direct | Jan 20, 2009 (4d) |
| Jan 16, 2009 | CLF | ↓ Sell | 2,898,376 | $22.03 | $63.8M | Direct | Jan 16, 2009 (0d) |
| Jan 14, 2009 | NAV | ↓ Sell | 228,434 | $26.88 | $6.1M | Direct | Jan 15, 2009 (1d) |
| Jan 12, 2009 | CLF | ↓ Sell | 528,912 | $27.62 | $14.6M | Direct | Jan 12, 2009 (0d) |
| Jan 8, 2009 | CLF | ↓ Sell | 1,370,938 | $28.60 | $39.2M | Direct | Jan 9, 2009 (1d) |
| Jan 7, 2009 | NAVZ | ↓ Sell | 500,000 | $30.71 | $15.4M | Direct | Jan 8, 2009 (1d) |
| Dec 26, 2008 | CPN | ↑ Buy | 480,700 | $6.73 | $3.2M | Direct | Dec 30, 2008 (4d) |
| Dec 5, 2008 | MEG | ↓ Sell | 602,778 | $1.53 | $921K | Direct | Dec 9, 2008 (4d) |
| Dec 4, 2008 | MEG | ↓ Sell | 75,978 | $1.60 | $122K | Direct | Dec 5, 2008 (1d) |
| Dec 3, 2008 | PLIAP | ↓ Sell | 72,500 | $0.31 | $22K | Direct | Dec 5, 2008 (2d) |
| Dec 2, 2008 | MEG | ↓ Sell | 184,450 | $1.65 | $304K | Direct | Dec 3, 2008 (1d) |
| Dec 2, 2008 | PLIAP | ↓ Sell | 10,489 | $1.23 | $13K | Direct | Dec 3, 2008 (1d) |
| Nov 26, 2008 | PBSO | ↓ Sell | 3,624,472 | $0.12 | $446K | Direct | Dec 1, 2008 (5d) |
| Nov 26, 2008 | MEG | ↓ Sell | 27,679 | $1.76 | $49K | Direct | Dec 1, 2008 (5d) |
| Nov 26, 2008 | PLIAP | ↓ Sell | 1,600 | $6.53 | $10K | Direct | Dec 1, 2008 (5d) |
| Nov 25, 2008 | MEG | ↓ Sell | 605,489 | $1.60 | $970K | Direct | Nov 26, 2008 (1d) |
| Nov 24, 2008 | PLIAP | ↓ Sell | 7,124 | $0.00 | $7 | Direct | Nov 26, 2008 (2d) |
| Nov 24, 2008 | CPN | ↑ Buy | 700,000 | $7.25 | $5.1M | Direct | Nov 25, 2008 (1d) |
| Nov 21, 2008 | MEG | ↓ Sell | 276,000 | $1.52 | $421K | Direct | Nov 24, 2008 (3d) |
| Nov 21, 2008 | NYT | ↑ Buy | 50,000 | $5.12 | $256K | Direct | Nov 24, 2008 (3d) |
| Nov 20, 2008 | AAWW | ↑ Buy | 16,600 | $9.05 | $150K | Direct | Nov 24, 2008 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Raymond J Harbert's insider trades
Raymond J Harbert is a 10% owner of Enzo Biochem (ENZ). Since May 4, 2005, Raymond has reported 393 open-market purchases worth $3.13B and 139 sales worth $1.43B on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (126 filings), grants and awards (16 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.